Kiwon lafiya, Shirye-shirye
Sia-ragewan miyagun ƙwayoyi "Rosuvastatin": umarnin don amfani da
Dauki kwaya "Rosuvastatin" manufacturer bada shawarar cewa mutanen da ke fama daga gauraye nau'i na hypercholesterolemia (rubuta IIb) hypercholesterolaemia ko IIa (ciki har da heterozygous) a matsayin adjunct don rage cin abinci.
Kamar wancan ne mafi girma da ya dace hypolipidemic aiki miyagun ƙwayoyi ne a cikin al'amarin a lokacin da wasu magani hanyoyin (wasan motsa jiki, rage jiki nauyi) ba su kai ga rabo daga wani dace warkewa sakamakon. Bugu da ƙari kuma, yi amfani zabe wakili "Rosuvastatin" umurci manual bada shawarar a matsayin karin miyagun ƙwayoyi a lokacin far homozygous hypercholesterolemia iyali da irin.
Sanya wadannan alluna an tsananin haramta idan akwai wani mai haƙuri mai tsanani hanta cututtuka, myopathy ko cuta da aka bayyana a cikin koda. A lokacin daukar ciki, kuma kada kai sia-ragewan kwayoyi "Rosuvastatin." A magani ne contraindicated a cikin lactation lokaci. Bugu da ƙari kuma, an ba da shawarar ya dauki wadannan alluna bi-biye da cyclosporine ko hypersensitivity to su gyara. Mutane masu ba su isa da shekaru goma sha takwas, da kuma ba lallai ba ne su sanya wani zabe wakili "Rosuvastatin." Umurnai na amfani ba rika yi da shi a cikin hali na barasa dogara kafa na koda gazawar ko hanta cututtuka.
Tare da babban kula yi amfani da sia-ragewan kwayoyi ya zama da mutanen da ke fama electrolyte, endocrine da kuma rayuwa cuta, hypothyroidism ko hypotension. A sepsis, uncontrolled epilepsy, proteinuria, manyan rauni, kuma m shisshigi ma ya kamata a daina shan miyagun ƙwayoyi, "Rosuvastatin." Bugu da kari, da dangi contraindications ne hereditary murdede cututtuka da kuma shekaru girmi shekara sittin da biyar.
A ƙarshe, ya kamata a ce game da yiwu m halayen, da ya faru na wanda za a iya jawo da liyafar nufin "Rosuvastatin." Alal misali, mutane da yawa marasa lafiya koka ciki zafi, maƙarƙashiya, dizziness da tashin zuciya. Bugu da kari, akwai kadan hadarin myopathy, proteinuria, asthenia , kuma myalgia.
Similar articles
Trending Now